BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 35101688)

  • 41. MicroRNA-126 Targeting PIK3R2 Inhibits NSCLC A549 Cell Proliferation, Migration, and Invasion by Regulation of PTEN/PI3K/AKT Pathway.
    Song L; Li D; Gu Y; Wen ZM; Jie J; Zhao D; Peng LP
    Clin Lung Cancer; 2016 Sep; 17(5):e65-e75. PubMed ID: 27236384
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Downregulation of long non-coding RNA XIST inhibits cell proliferation, migration, invasion and EMT by regulating miR-212-3p/CBLL1 axis in non-small cell lung cancer cells.
    Qiu HB; Yang K; Yu HY; Liu M
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8391-8402. PubMed ID: 31646569
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Downregulation of miR-133a-3p promotes prostate cancer bone metastasis via activating PI3K/AKT signaling.
    Tang Y; Pan J; Huang S; Peng X; Zou X; Luo Y; Ren D; Zhang X; Li R; He P; Wa Q
    J Exp Clin Cancer Res; 2018 Jul; 37(1):160. PubMed ID: 30021600
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer.
    Ma T; Chen H; Wang P; Yang N; Bao J
    Cancer Biother Radiopharm; 2020 Nov; 35(9):661-672. PubMed ID: 32275162
    [No Abstract]   [Full Text] [Related]  

  • 45. OSCC Exosomes Regulate miR-210-3p Targeting EFNA3 to Promote Oral Cancer Angiogenesis through the PI3K/AKT Pathway.
    Wang H; Wang L; Zhou X; Luo X; Liu K; Jiang E; Chen Y; Shao Z; Shang Z
    Biomed Res Int; 2020; 2020():2125656. PubMed ID: 32695810
    [TBL] [Abstract][Full Text] [Related]  

  • 46. miR-574-3p inhibits proliferation and invasion in esophageal cancer by targeting FAM3C and MAPK1.
    Jin LL; Zhang SJ; Lu GX; Lv F; Shang R; Yang J
    Kaohsiung J Med Sci; 2020 May; 36(5):318-327. PubMed ID: 31880039
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MicroRNA-103a-3p Promotes Cell Proliferation and Invasion in Non-Small-Cell Lung Cancer Cells through Akt Pathway by Targeting PTEN.
    Li H; Huhe M; Lou J
    Biomed Res Int; 2021; 2021():7590976. PubMed ID: 34307670
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bioinformatics identification of miR-514b-5p promotes NSCLC progression and induces PI3K/AKT and p38 pathways by targeting small glutamine-rich tetratricopeptide repeat-containing protein beta.
    Shi L; Kan J; Zhuo L; Wang S; Chen S; Zhang B; Ke B
    FEBS J; 2023 Feb; 290(4):1134-1150. PubMed ID: 36180981
    [TBL] [Abstract][Full Text] [Related]  

  • 49. miR-135a Confers Resistance to Gefitinib in Non-Small Cell Lung Cancer Cells by Upregulation of RAC1.
    Zhang T; Wang N
    Oncol Res; 2018 Sep; 26(8):1191-1200. PubMed ID: 29386087
    [TBL] [Abstract][Full Text] [Related]  

  • 50. GINS2 facilitates epithelial-to-mesenchymal transition in non-small-cell lung cancer through modulating PI3K/Akt and MEK/ERK signaling.
    Liu X; Sun L; Zhang S; Zhang S; Li W
    J Cell Physiol; 2020 Nov; 235(11):7747-7756. PubMed ID: 31681988
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Down-regulation of mir-27b promotes angiogenesis and fibroblast activation through activating PI3K/AKT signaling pathway.
    Sun F; Bi Q; Wang X; Liu J
    Wound Repair Regen; 2020 Jan; 28(1):39-48. PubMed ID: 31587435
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Up-regulation of miR-133a-3p promotes ovary insulin resistance on granulosa cells of obese PCOS patients via inhibiting PI3K/AKT signaling.
    Yang X; Wang K; Lang J; Guo D; Gao H; Qiu Y; Jin X; Zhang M; Shi J; Ma Q; Ma Q; Wen Z
    BMC Womens Health; 2022 Oct; 22(1):412. PubMed ID: 36209087
    [TBL] [Abstract][Full Text] [Related]  

  • 53. microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C.
    Hu J; Cheng Y; Li Y; Jin Z; Pan Y; Liu G; Fu S; Zhang Y; Feng K; Feng Y
    Eur J Cancer; 2014 Sep; 50(13):2336-50. PubMed ID: 25001183
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Circ_0000376 downregulation inhibits the progression of non-small cell lung cancer by mediating the miR-488-3p/BRD4 axis and the PI3K/PKB signaling pathway.
    Yuan H; Wu H; Cheng J; Xiong J
    Histol Histopathol; 2021 Dec; 36(12):1309-1324. PubMed ID: 34730838
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Metapristone suppresses non-small cell lung cancer proliferation and metastasis via modulating RAS/RAF/MEK/MAPK signaling pathway.
    Zheng G; Shen Z; Chen H; Liu J; Jiang K; Fan L; Jia L; Shao J
    Biomed Pharmacother; 2017 Jun; 90():437-445. PubMed ID: 28391165
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MicroRNA-107 inhibits tumor growth and metastasis by targeting the BDNF-mediated PI3K/AKT pathway in human non-small lung cancer.
    Xia H; Li Y; Lv X
    Int J Oncol; 2016 Oct; 49(4):1325-33. PubMed ID: 27498977
    [TBL] [Abstract][Full Text] [Related]  

  • 57. LncRNA SNHG1 influences cell proliferation, migration, invasion, and apoptosis of non-small cell lung cancer cells via the miR-361-3p/FRAT1 axis.
    Li X; Zheng H
    Thorac Cancer; 2020 Feb; 11(2):295-304. PubMed ID: 31788970
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MicroRNA-1915-3p inhibits cell migration and invasion by targeting SET in non-small-cell lung cancer.
    Pan H; Pan Z; Guo F; Meng F; Zu L; Fan Y; Li Y; Li M; Du X; Zhang X; Shao Y; Wei M; Li X; Zhou Q
    BMC Cancer; 2021 Nov; 21(1):1218. PubMed ID: 34774019
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Upregulation of miR-133a-3p enhances Bufothionine-induced gastric cancer cell death by modulating IGF1R/PI3K/Akt signal pathway mediated ER stress.
    Hu ZH; Wang GJ; Li RX; Zhu TY; Wang ZY; Ding HX; Hu XM
    Life Sci; 2020 Oct; 259():118180. PubMed ID: 32758622
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MicroRNA-7 inhibits cell proliferation, migration and invasion in human non-small cell lung cancer cells by targeting FAK through ERK/MAPK signaling pathway.
    Cao Q; Mao ZD; Shi YJ; Chen Y; Sun Y; Zhang Q; Song L; Peng LP
    Oncotarget; 2016 Nov; 7(47):77468-77481. PubMed ID: 27764812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.